Prognostic implications of combining EGFR‐TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19‐Del or 21‐L858R mutations: A real‐world study

Abstract Objective To elucidate the potential benefits of combining radiotherapy and epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) for individuals with Stage IV lung adenocarcinoma (LUAD) harboring either exon 19 deletion (19‐Del) or exon 21 L858R mutation (21‐L858R). Metho...

Descripción completa

Detalles Bibliográficos

Autores principales:	Shuai Liang, Hanyu Wang, Yingyun Zhang, Haixia Tian, Chengming Li, Dong Hua
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2024-04-01
Colección:	Cancer Medicine
Materias:	epidermal growth factor receptor‐tyrosine kinase inhibitor exon 19 deletion exon 21 L858R mutation radiotherapy Stage IV lung adenocarcinoma
Acceso en línea:	https://doi.org/10.1002/cam4.7208
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!